Amy Welsh
Corporate Officer/Principal bei AGILE THERAPEUTICS, INC.
Vermögen: 4 874 $ am 31.05.2024
Aktive Positionen von Amy Welsh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AGILE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.11.2022 | - |
| Vertrieb & Marketing | 01.05.2020 | 01.11.2022 |
Karriereverlauf von Amy Welsh
Ehemalige bekannte Positionen von Amy Welsh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ANTARES PHARMA, INC. | Vertrieb & Marketing | 01.06.2017 | 01.05.2020 |
Ausbildung von Amy Welsh
| LaSalle University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Sales & Marketing | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
